Kimberly-Clark has begun restructuring preparations for its planned Kenvue acquisition by offering holders of Kenvue notes an exchange for up to US$7 billion in new Kimberly-Clark debt securities and cash. The move is aimed at aligning the companies’ financing structures ahead of the merger. 

Why it matters: Huntington’s disease causes progressive movement, cognitive and behavioral problems, with no approved treatment that slows its progression. AMT-130 could offer a first disease-modifying option, but its evidence relies on a small patient group compared with an external database.

Swiss skin care brand Instytutum has reported that its complete skin care routine reduced calculated skin biological age by three years after 84 days of use. The new clinical data supports the company’s approach to biological skin aging.

Zoom in: Novo Holdings and the Ljungström family office co-led the Swedish biotech’s Series B. The financing will fund a roughly 400-patient trial, with the aim of making AC01 ready for Phase 3 by 2028.

Why it matters: The Milan-based company is trying to reverse the gene silencing that causes the condition, rather than treat its downstream effects. Aptadir says that its lead candidate, CAP1-FMR1, has restored gene expression and function in patient-derived disease models.

Unilever is strengthening its manufacturing footprint in Egypt with a new Sunsilk production line at its Mashreq Personal Care (MPC) factory in 6th of October City, a satellite city of Cairo. Reports have revealed that the consumer goods company continues to position the country as a regional production and export base.

Why it matters: The Series A round positions Breye to generate clinical proof-of-concept data on a drug candidate that could change how physicians treat non-proliferative diabetic retinopathy (NPDR). Breye’s lead program, danegaptide, is an oral challenger for a market dominated by therapies that are injected into the eye.

A FMC Corporation informou que protocolou o dossiê regulatório e pediu registro da molécula rimisoxafen junto às autorid…

Foto: Wesley Santos  O plantio da safra de soja 2026/27 em Mato Grosso do Sul avançou, até 25 de setembro, para 5,1…